The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Increased Vancomycin MICs for Staphylococcus aureus Clinical Isolates from a University Hospital during a 5-Year Period
Open accessAbstract
Staphylococcus aureus is one of the most commonly isolated organisms in nosocomial infections. While the prevalence of methicillin-resistant S. aureus (MRSA) continues to increase worldwide, there is concern about an increase in vancomycin MICs among S. aureus strains. The prevalence of MRSA and vancomycin MIC trends in S. aureus from patients in a university hospital were analyzed. Clinical Laboratory Standards Institute (CLSI, formerly NCCLS) reference broth microdilution MIC testing was performed on all clinically relevant S. aureus isolates from January 2000 through December 2004. A total of 6,003 S. aureus isolates were analyzed. No vancomycin-resistant S. aureus isolates were detected. One MRSA isolate had a vancomycin MIC of 8 μg/ml and was confirmed as vancomycin-intermediate S. aureus . Among the 6,002 remaining isolates, a shift in vancomycin MICs from ≤0.5 to 1.0 μg/ml was observed during the 5-year period. The percentage of S. aureus isolates with a vancomycin MIC of 1 μg/ml in 2004 was significantly higher than the percentage of isolates in 2000 (70.4% versus 19.9%; P < 0.01). This vancomycin MIC shift was more notable in methicillin-susceptible S. aureus . Our 5 years of routine testing of clinical isolates using the CLSI reference broth microdilution MIC method demonstrated a tendency toward decreasing susceptibility to vancomycin in S. aureus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836
Methicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Salgado, C. D., Farr, B. M., & Calfee, D. P. (2003) · Clinical Infectious Diseases · doi:10.1086/345436 · Cited by 790
Nosocomial Infections in Pediatric Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, T. N. N. I. S. (1999) · Pediatrics · doi:10.1542/peds.103.4.e39 · Cited by 572
Staphylococcus aureus resistant to vancomycin--United States, 2002.
(2002) · PubMed · Cited by 569
Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002
Tiemersma, E. W., Bronzwaer, S. L. A. M., Lyytikäinen, O., Degener, J. E., Schrijnemakers, P., Bruinsma, N., Monen, J., Witte, W., Grundmann, H., & Participants, E. A. R. S. S. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1009.040069 · Cited by 528
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484
(2004) · PubMed · doi:10.1016/s0196655304005425 · Cited by 465
Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O’Hara, C. M., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.1020-1027.1998 · Cited by 376
Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O’Hara, C. M., McAllister, S. K., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.2167-2167.1998 · Cited by 362
Fridkin, S. K., Hageman, J., McDougal, L. K., Mohammed, J., Jarvis, W. R., Perl, T. M., Tenover, F. C., & the Vancomycin‐Intermediate Staphylococcus aureus Epidemiology Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/346207 · Cited by 344 · cited 1×
“aureus with reduced susceptibility to vancomycin and other glycopeptides (11, 13, 26, 28, 30).”
BackgroundMoise-Broder, P. A., Sakoulas, G., Eliopoulos, G. M., Schentag, J. J., Forrest, A., & Moellering, R. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421092 · Cited by 332
Weinstein, R. A., & Fridkin, S. K. (2001) · Clinical Infectious Diseases · doi:10.1086/317542 · Cited by 304
Mercuri, E., Rutherford, M., Cowan, F., Pennock, J., Counsell, S., Papadimitriou, M., Azzopardi, D., Bydder, G., & Dubowitz, L. (1999) · Pediatrics · doi:10.1542/peds.103.1.39 · Cited by 298
Vancomycin-resistant Staphylococcus aureus--New York, 2004.
(2004) · PubMed · Cited by 252
Vancomycin-Resistant Staphylococcus aureus--Pennsylvania, 2002
(2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.17.2116 · Cited by 228
The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus Aureus
Walsh, T. R., & Howe, R. A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160806 · Cited by 215
Vancomycin-resistant staphylococci and enterococci: epidemiology and control
Tenover, F. C., & McDonald, L. C. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000171923.62699.0c · Cited by 200
The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
Hiramatsu, K. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00149-1 · Cited by 191
Emergence in Asian Countries of Staphylococcus aureus with Reduced Susceptibility to Vancomycin
Song, J., Hiramatsu, K., Suh, J. Y., Ko, K. S., Ito, T., Kapi, M., Kiem, S., Ys, K., Oh, W. S., Peck, K. R., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4926-4928.2004 · Cited by 114
Καντζάνου, Μ., Tassios, P. T., Tseleni-Kotsovili, A., Legakis, N. I., & Vatopoulos, A. C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.5.729 · Cited by 55
van Griethuysen, A. J., Veen, A. V. '., Buiting, A. G. M., Walsh, T. R., & Kluytmans, J. A. J. W. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2487-2491.2003 · Cited by 49
Hussain, F., Boyle‐Vavra, S., Shete, P. B., & Daum, R. S. (2002) · The Journal of Infectious Diseases · doi:10.1086/342708 · Cited by 49
Cartolano, G.-L., Cheron, M., Benabid, D., Leneveu, M., & Boisivon, A. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00830.x · Cited by 44
Marlowe, E. M., Cohen, M. D., Hindler, J. F., Ward, K. W., & Bruckner, D. A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2637-2639.2001 · Cited by 31
Self-citationThe real vancomycin-resistant Staphylococcus aureus has arrived
Tenover, F. C. (2005) · Clinical Microbiology Newsletter · doi:10.1016/s0196-4399(05)80005-4 · Cited by 17
Chapman, A. L. N., Greig, J. M., & Innes, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejm200508043530521 · Cited by 9
Cited by
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
“and the increasing prevalence of non-susceptible strain”
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
“While this approach is not currently supported by evidence from large randomized clinical trials, vancomycin loading doses can be considered in the treatment of serious MRSA infections.(63,74)”
BackgroundCoagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,628
Metadata
- Authors
- Wang, G., Hindler, J. F., Ward, K. W., & Bruckner, D. A.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2006-11
- Volume
- 44
- Issue
- 11
- Pages
- 3883-3886
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2056829631
- Cited by
- 358
- References
- 32
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.